Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old

British Journal of Clinical Pharmacology

Volumn , Issue , 2016, Pages 1382-1392

  Wauters, Maarten ^a   Elseviers, Monique ^a   Vaes, Bert ^b,c   Degryse, Jan ^b,c   Dalleur, Olivia ^b,d   Vander Stichele, Robert ^a   Christiaens, Thierry ^a   Azermai, Majda ^a  

^a GHENT UNIVERSITY   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

aged 80 years and over; hospitalization; inappropriate prescribing; mortality; polypharmacy; primary care

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CALCIUM; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IPRATROPIUM BROMIDE; LAXATIVE; LOOP DIURETIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PRASUGREL; SEROTONIN UPTAKE INHIBITOR; TIOTROPIUM BROMIDE; VITAMIN D;

AGED; ARTICLE; COHORT ANALYSIS; DEATH; DRUG MISUSE; DRUG UNDERUSE; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SURVIVAL ANALYSIS; UNIVARIATE ANALYSIS;

EID: 84991224444     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.13055     Document Type: Article

References (51)

1. Laroche M-L, Charmes J-P, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007; 63: 177–186.
2. Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010; 107: 543–551.
3. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Prescribing in elderly people. 1. Appropriate prescribing in elderly people : how well can it be measured and optimised? Lancet 2007; 370: 173–184.
4. Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol 2014; 77: 1073–1082.
5. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825–1832.
6. Page RL, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 2010; 5: 75–87.
7. Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007; 32: 113–121.
8. Kaufmann CP, Tremp R, Hersberger KE, Lampert ML. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol 2014; 70: 1–11.
9. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616–631.
10. O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 2: 213–218.
11. Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725–731.
12. Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc 2014; 62: 1658–1665.
13. Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013–1019.
14. García-Gollarte F, Baleriola-Júlvez J, Ferrero-López I, Cuenllas-Díaz Á, Cruz-Jentoft AJ. An educational intervention on drug use in nursing homes improves health outcomes resource utilization and reduces inappropriate drug prescription. J Am Med Dir Assoc 2014; 15: 885–891.
15. Meid AD, Quinzler R, Freigofas J, Saum K-U, Schöttker B, Holleczek B, et al. Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study. PLoS One 2015; 10: e0136339.
16. Moriarty F, Bennett K, Fahey T, Kenny RA, Cahir C. Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people. Eur J Clin Pharmacol 2015; 71: 473–482.
17. Cahir C, Bennett K, Teljeur C, Fahey T. Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol 2014; 77: 201–210.
18. Dalleur O, Boland B, De Groot A, Vaes B, Boeckxstaens P, Azermai M, et al. Detection of potentially inappropriate prescribing in the very old: cross-sectional analysis of the data from the BELFRAIL observational cohort study. BMC Geriatr 2015; 15: 156.
19. Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol 2015; 1415–27.
20. Vaes B, Pasquet A, Wallemacq P, Rezzoug N, Mekouar H, Olivier P-A, et al. The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr 2010; 10: 39.
21. Wauters M, Elseviers M, Vaes B, Degryse J, Dalleur O, Vander Stichele R, et al. Polypharmacy in a Belgian cohort of community-dwelling oldest old (80+). Acta Clin Belg 2016; 71: 158–166.
22. WHO. The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). Oslo, Norway: World Health Organization.
23. Veehof LJG, Stewart RE, Haaijer-Ruskamp FM, Meyboom-de Jong B. The development of polypharmacy. Fam Pract 2000; 17: 261–267.
24. Levy HB, Marcus E-L, Christen C. Beyond the Beers criteria: A comparative overview of explicit criteria. Ann Pharmacother 2010; 44: 1968–1975.
25. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83.
26. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O'Sullivan D, Christie R. Application of the STOPP/START criteria: A systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharmacol Ther 2013; 38: 360–372.
27. Ryan C, O'Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother 2009; 43: 1239–1244.
28. Wauters M, Elseviers M, Vaes B, Degryse J, Vander Stichele R, Christiaens T, et al. Mortality, hospitalisation, and institutionalisation in a community-dwelling cohort of oldest old: the impact of medication. Arch Gerontol Geriatr 2016; 65: 9–16.
29. Bjerre LM, Ramsay T, Cahir C, Ryan C, Halil R, Farrell B, et al. Assessing potentially inappropriate prescribing (PIP) and predicting patient outcomes in Ontario's older population: a population-based cohort study applying subsets of the STOPP/START and Beers' criteria in large health administrative databases. BMJ Open 2015; 5: e010146.
30. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011; 89: 845–854.
31. San-José A, Agustí A, Vidal X, Formiga F, Gómez-Hernández M, García J, et al. Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors. BMC Geriatr 2015; 15: 1–9.
32. Lang PO, Hasso Y, Dramé M, Vogt-Ferrier N, Prudent M, Gold G, et al. Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities. Age Ageing 2010; 39: 373–381.
33. Dalleur O, Spinewine A, Henrard S, Losseau C, Speybroeck N, Boland B. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging 2012; 29: 829–837.
34. Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol 2015; 71: 861–875.
35. Barry PJ, Gallagher P, Ryan C, O'mahony D. START (screening tool to alert doctors to the right treatment)--an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 632–638.
36. Ryan C, O'Mahony D, Kennedy J, Weedle P, Byrne S. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol 2009; 68: 936–947.
37. Vezmar Kovačević S, Simišić M, Stojkov Rudinski S, Ćulafić M, Vučićević K, Prostran M, et al. Potentially inappropriate prescribing in older primary care patients. Quinn TJ, editor. PLoS One 2014; 9: e95536.
38. Wahab MSA, Nyfort-Hansen K, Kowalski SR. Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria. Int J Clin Pharmacol 2012; 34: 855–862.
39. Fick DM, Mion LC, Beers MH, Waller JL. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 2008; 31: 42–51.
40. Albert SM, Colombi A, Hanlon J. Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database. Drugs Aging 2010; 27: 407–415.
41. Dedhiya SD, Hancock E, Craig BA, Doebbeling CC, Thomas J. Incident use and outcomes associated with potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother 2010; 8: 562–570.
42. Gosch M, Wörtz M, Nicholas JA, Doshi HK, Kammerlander C, Lechleitner M. Inappropriate prescribing as a predictor for long-term mortality after hip fracture. Gerontology 2014; 60: 114–122.
43. Meid AD, Lampert A, Burnett A, Seidling HM, Haefeli WE. The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol 2015; 80: 768–776.
44. Meid AD, Haefeli WE. Age-Dependent Impact of Medication Underuse and Strategies for Improvement. Gerontology. Karger Publishers; 2016; 62: 491–499.
45. Viktil KK, Blix HS, Reikvam Å. The Janus face of polypharmacy – overuse versus underuse of medication. Norsk Epidemiologi 2008; 147–152.
46. Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 2004; 291: 1864–1870.
47. Topinková E, Baeyens JP, Michel J-P, Lang P-O. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012; 29: 477–494.
48. Huybrechts KF, Gerhard T, Franklin JM, Levin R, Crystal S, Schneeweiss S. Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research. Pharmacoepidemiol Drug Saf 2014; 23: 830–838.
49. de Groot DA, de Vries M, Joling KJ, van Campen JPCM, Hugtenburg JG, van Marum RJ, et al. Specifying ICD9, ICPC and ATC codes for the STOPP/START criteria: a multidisciplinary consensus panel. Age Ageing 2014; 43: 773–778.
50. Dentler K, Numans ME, ten Teije A, Cornet R, de Keizer NF. Formalization and computation of quality measures based on electronic medical records. J Am Med Inform Assoc 21: 285–291.
51. Moreno-Conde A, Moner D, da Cruz WD, Santos MR, Maldonado JA, Robles M, et al. Clinical information modeling processes for semantic interoperability of electronic health records: systematic review and inductive analysis. J Am Med Inform Assoc 2015; 22: 925–934.